Lofexidine for Opiate Withdrawal - 1
Status and phase
Conditions
Treatments
Details and patient eligibility
About
The purpose of this study is to evaluate lofexidine for opiate withdrawal.
Full description
An 11 day inpatient placebo-controlled, double-blind study of 96 opiate dependent, treatment seeking individuals randomized to 2 medication groups: lofexidine and placebo to be conducted in inpatient units at 3 treatment sites.
Sex
Ages
Volunteers
Inclusion criteria
Male or female as least 18 yrs of age & above with a current dependence on heroin, morphine or hydromorphone according to DSM4 criteria; subject ; voluntarily given consent and signed informed consent; females using appropriate birth control method.
Exclusion criteria
Additional criteria available during screening at the site
Trial design
Primary purpose
Allocation
Interventional model
Masking
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal